Table 1.
Description of study population
| All (n=261) Nb (%) | Male Nb (%) | Female Nb (%) | P | |
|---|---|---|---|---|
| Age (in years) | ||||
| 18-39 | 81 (31.0) | 61 (34.5) | 20 (23.8) | 0.043 |
| 40-59 | 117 (44.8) | 70 (39.5) | 47 (56.0) | |
| ≥60 | 63 (24.1) | 46 (26.0) | 17 (20.2) | |
| Gender | ||||
| Male | 177 (43.7) | |||
| Female | 84 (32.2) | |||
| Number of comorbid conditions | ||||
| None | 114 (43.7) | 86 (48.6) | 28 (33.3) | 0.017 |
| ≤2 | 125 (47.9) | 74 (41.8) | 51 (60.7) | |
| >2 | 22 (8.4) | 17 (9.6) | 5 (5.9) | |
| Number of symptoms at time of RT-PCR testing | ||||
| None | 13 (5.0) | 11 (6.2) | 2 (2.4) | 0.025 |
| 1-5 | 147 (56.3) | 106 (59.9) | 41 (48.8) | |
| 6-10 | 84 (32.2) | 53 (29.9) | 31 (36.9) | |
| >10 | 17 (6.5) | 7.0 (4.0) | 10 (11.9) | |
| Number of symptoms 14 to 21 days after RT-PCR testing (immediate period) | ||||
| None | 117 (44.8) | 85 (48.0) | 32 (38.1) | 0.003 |
| 1-5 | 139 (53.3) | 92 (52.1) | 47 (56.0) | |
| 6-10 | 05 (1.9) | - | 5 (6.0) | |
| >10 | - | - | - | |
| Returned to usual health 14 to 21 days after RT-PCR testing (immediate period) | ||||
| Yes | 117 (44.8) | 85 (48.0) | 32 (38.1) | 0.084 |
| No | 144 (55.2) | 92 (52.0) | 52 (61.9) | |
| Number of symptoms 90 to 97 days after immediate period (short-term period) | ||||
| None | 190 (72.8) | 129 (72.9) | 61 (72.6) | 0.038 |
| 1-5 | 68 (26.1) | 48 (27.1) | 20 (23.8) | |
| 6-10 | 03 (1.1) | - | 03 (3.6) | |
| >10 | - | - | - | |
| Returned to usual health 90 to 97 days after immediate period (short-term period) | ||||
| Yes | 190 (72.8) | 129 (72.9) | 61 (72.6) | 0.538 |
| No | 71 (27.2) | 48 (27.1) | 23 (27.4) | |
| Depression 14 to 21 days after RT-PCR testing (immediate period) | ||||
| No | 228 (87.4) | 159 (89.8) | 69 (82.2) | 0.063 |
| Yes | 33 (12.6) | 18 (10.2) | 15 (17.9) | |
| Depression 90 to 97 days after immediate period (short-term period) | ||||
| No | 248 (95.0) | 170 (96.0) | 78 (92.9) | 0.36 |
| Yes | 13 (5.0) | 7 (4.0) | 06 (7.1) |